• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE INC FREESTYLE LIBRE 2; FLASH GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE INC FREESTYLE LIBRE 2; FLASH GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 71992-01
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Erythema (1840); Unspecified Infection (1930); Itching Sensation (1943)
Event Date 08/17/2020
Event Type  Injury  
Manufacturer Narrative
At this time product has not yet been returned.An extended investigation has been performed for the reported complaint.There was no indication that the product did not meet specification.The reported complaint is related to skin irritation or an allergic reaction to the patch adhesive of the freestyle libre sensor.Dhrs (device history review) for the freestyle libre sensor and freestyle libre sensor kit were reviewed and the dhrs showed the freestyle libre sensor and freestyle libre sensor kit passed all tests prior to release.Dose audit reports were reviewed and demonstrates the continued effectiveness of the established sterilization process for libre sensor products.Environmental monitoring reports were reviewed, including bioburden and endotoxin testing, and demonstrated that all monitoring processes continue to meet adc minimum requirements for product quality.If the product is returned, a physical investigation will be performed and a follow-up report submitted.All pertinent information available to abbott diabetes care has been submitted.
 
Event Description
A customer reported experiencing a skin reaction while wearing the adc freestyle libre sensor, with symptoms of itching, redness, and ¿insertion site infection¿.The customer had contact with a healthcare provider and received an unspecified antibiotic and polaramine (antihistamine) as treatment.There was no report of death or permanent impairment associated with this event.
 
Event Description
A customer reported experiencing a skin reaction while wearing the adc freestyle libre sensor, with symptoms of itching, redness, and ¿insertion site infection¿.The customer had contact with a healthcare provider and received an unspecified antibiotic and polaramine (antihistamine) as treatment.There was no report of death or permanent impairment associated with this event.
 
Manufacturer Narrative
Sensor(b)(6) has been returned and investigated.No physical damage was observed on the sensor patch and no issues were observed with the sensor adhesive.The sensor sharp was not returned.No malfunction or product deficiency was identified.All pertinent information available to abbott diabetes care has been submitted.Additional information - section g1: (contact office first name, contact office last name, contact office phone number and contact office email) has been updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRE 2
Type of Device
FLASH GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
ABBOTT DIABETES CARE INC
1360 south loop road
alameda CA 94502 7001
MDR Report Key10573508
MDR Text Key208128501
Report Number2954323-2020-06480
Device Sequence Number1
Product Code QLG
Combination Product (y/n)N
PMA/PMN Number
K193371
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 03/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date09/30/2021
Device Model Number71992-01
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/09/2020
Initial Date Manufacturer Received 09/16/2020
Initial Date FDA Received09/23/2020
Supplement Dates Manufacturer Received02/10/2021
Supplement Dates FDA Received03/08/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age39 YR
Patient Weight75
-
-